Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03216421 · ClinicalTrials.gov registry record · NA

Intraoperative Radiation Therapy (IORT) in DCIS

A NA study of Breast Cancer and Ductal Carcinoma In Situ, sponsored by Columbia University.

Active
Registry status
NA
Development phase
265
Enrollment target
1
Study location

NCT03216421 is a NA study of Breast Cancer and Ductal Carcinoma In Situ that is active but no longer recruiting, run by Columbia University. The registered enrollment target is 265 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03216421, a NA study of Breast Cancer and Ductal Carcinoma In Situ, is active but no longer recruiting, sponsored by Columbia University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
265 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to examine the role of Intraoperative Radiotherapy (IORT) in Ductal Carcinoma In-Situ (DCIS) and to improve the understanding of the clinical, radiographic, and patient-related impact of adopting IORT.

Interventions

  • OTHER Quality of Life Questionnaires

Study Locations (1)

New York

  • Columbia University Irving Medical Center - New York

Trial Details

FieldValue
Enrollment Target 265 participants
Start Date 2017-09-12
Est. Completion 2029-12-31
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT03216421

The ClinicalTrials.gov registry entry for NCT03216421 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 265 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Quality of Life Questionnaires is the first listed.

NCT03216421 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03216421 about?

NCT03216421 is a clinical study titled "Intraoperative Radiation Therapy (IORT) in DCIS". The goal of this study is to examine the role of Intraoperative Radiotherapy (IORT) in Ductal Carcinoma In-Situ (DCIS) and to improve the understanding of the clinical, radiographic, and patient-related impact of adopting IORT.

What is the current status of trial NCT03216421?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 265 participants. The study started on 2017-09-12. Estimated completion is 2029-12-31.

What conditions does trial NCT03216421 study?

This clinical trial studies the following conditions: Breast Cancer, Ductal Carcinoma In Situ.

What interventions are being tested in trial NCT03216421?

The interventions under investigation include: Quality of Life Questionnaires (OTHER).

Who is sponsoring clinical trial NCT03216421?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03216421 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.